Andere talen Bio-Techne Corporation

Aandelen

TECH

US09073M1045

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
63,69 ^USD	+1,42%		-0,50%	-17,46%

18/04	BIO-TECHNE CORPORATION : Deutsche Bank Securities is Neutraal gestemd over aandeel	ZM
08/04	BIO-TECHNE CORPORATION : RBC Capital Markets vindt het aandeel niet inspirerend	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	23/04
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23/04
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	10/04
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	08/04
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	01/04
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	28/03
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	28/03
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	25/03
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	22/03
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	22/03
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES AND MEDTECH INVESTOR FORUM	13/03
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM	12/03
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE	06/03
Année faste en 2023 pour les levées de fonds à l'EPFL	12/02
North American Morning Briefing : Hopes of March -2-	05/02
Bio-Techne Seeks M&A	01/02
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	01/02
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	01/02
BIO-TECHNE DECLARES DIVIDEND	01/02
BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS	01/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bio-Techne Corporation

Aandelen

TECH

US09073M1045

Andere talen

Filters